TUDOR INVESTMENT CORP ET AL - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 267 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2024. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$777,080
+95.2%
19,427
+201.8%
0.00%
+33.3%
Q4 2023$398,067
-64.7%
6,436
-73.7%
0.00%
-72.7%
Q3 2023$1,126,893
-18.7%
24,503
+1.6%
0.01%
-35.3%
Q2 2023$1,385,429
+230804.8%
24,107
+50.6%
0.02%
+88.9%
Q1 2023$600
-99.9%
16,010
-47.8%
0.01%
-67.9%
Q2 2022$1,067,000
-26.4%
30,676
-24.1%
0.03%
-17.6%
Q1 2022$1,450,000
+42.4%
40,395
-7.6%
0.03%
+100.0%
Q4 2021$1,018,000
+23.2%
43,712
+0.6%
0.02%
+30.8%
Q3 2021$826,000
+9.4%
43,459
+16.1%
0.01%
-7.1%
Q2 2021$755,000
-5.9%
37,433
-14.5%
0.01%
-12.5%
Q1 2021$802,000
+52.8%
43,789
+67.6%
0.02%
+6.7%
Q4 2020$525,000
+2.3%
26,122
-26.2%
0.02%
-6.2%
Q1 2017$513,000
+5.3%
35,387
+33.9%
0.02%
+23.1%
Q4 2016$487,000
-3.9%
26,427
-1.2%
0.01%
+8.3%
Q3 2016$507,000
+3.9%
26,743
-11.7%
0.01%
+20.0%
Q2 2016$488,000
+99.2%
30,276
+48.5%
0.01%
+66.7%
Q1 2016$245,00020,3890.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2024
NameSharesValueWeighting ↓
Summit Global Investments 58,640$870,0000.13%
FEDERATED HERMES, INC. 2,600,120$38,586,0000.11%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 284,328$4,219,0000.07%
SILVERCREST ASSET MANAGEMENT GROUP LLC 291,352$4,324,0000.05%
MARSHALL WACE, LLP 301,910$4,481,0000.04%
MARTINGALE ASSET MANAGEMENT L P 212,817$3,159,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 171,266$2,542,0000.03%
WINTON GROUP Ltd 82,402$1,223,0000.03%
EAGLE ASSET MANAGEMENT INC 317,988$4,718,0000.03%
Engineers Gate Manager LP 24,007$356,0000.03%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders